These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29515071

  • 1. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 2. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [Abstract] [Full Text] [Related]

  • 3. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.
    Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568
    [Abstract] [Full Text] [Related]

  • 4. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [Abstract] [Full Text] [Related]

  • 5. Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis.
    Povey H, Vundru R, Junglee N, Jibani M.
    Clin Nephrol; 2014 Nov; 82(5):326-31. PubMed ID: 23557793
    [Abstract] [Full Text] [Related]

  • 6. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [Abstract] [Full Text] [Related]

  • 7. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.
    Yasuda S, Yamamoto M, Fukuda T, Ohtsuka Y, Miura O.
    Intern Med; 2016 Jul; 55(9):1171-5. PubMed ID: 27150874
    [Abstract] [Full Text] [Related]

  • 8. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 9. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T, Watarai Y, Futamura K, Okada M, Tsujita M, Hiramitsu T, Goto N, Narumi S, Takeda A, Kobayashi T.
    Transplant Proc; 2017 Apr 29; 49(1):159-162. PubMed ID: 28104125
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr 29; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 15. Relapse of Atypical Hemolytic Uremic Syndrome During Pregnancy in a Patient on Eculizumab Maintenance Treatment: A Case Report.
    Fontana F, Alfano G, Bardhushi E, Ligabue G, Giovanella S, Neri I, Cappelli G.
    Am J Case Rep; 2019 Oct 04; 20():1460-1465. PubMed ID: 31582717
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 04; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 17. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 04; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 18. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C, Büttner-Herold M, Bertz S, Schiffer M, Buchholz B.
    BMC Nephrol; 2020 Mar 24; 21(1):104. PubMed ID: 32204691
    [Abstract] [Full Text] [Related]

  • 19. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H.
    Intern Med; 2018 Jun 01; 57(11):1617-1623. PubMed ID: 29434134
    [Abstract] [Full Text] [Related]

  • 20. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
    Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
    Rinsho Ketsueki; 2018 Jun 01; 59(2):178-181. PubMed ID: 29515070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.